hypertension
Conditions
Interventions
Experimental group:Tablet containing casein hydrolysates
Control group:Placebo
Sponsors
Medical College of Qingdao University
Eligibility
Sex/Gender
All
Age
30 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) aged bewteen 30-65 years 2) if either of the two conditions are met can be included: those whose systolic blood pressure is between 120 to 159 mmHg and/or 80 to 99 mmHg of diastolic blood pressure 3) subjects who had signed written informed consent prior to the commencement of the study
Exclusion criteria
Exclusion criteria: 1) Allergic to dairy products or tested products 2) During pregnancy or breastfeeding 3) Patients with serious systemic diseases such as liver, kidney and hematopoietic syste 4) Those who do not take the tested product in accordance with the regulations, cannot judge the efficacy or affect the efficacy judgment due to incomplete data 5) Long-term use of blood pressure medication 6) Unwilling to sign written informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| diastolic blood pressure;systolic blood pressure; | — |
Secondary
| Measure | Time frame |
|---|---|
| heart rate;lipid profiles (total cholesterol, triglycerides, high density lipoprotein, low density lipoprotein);Serum electrolyte levels (potassium, calcium, sodium, magnesium, aluminum);Other biochemical markers (endothelin-1, plasma renin activity, angiotensin II, nitrogen oxides);Liver and kidney function (albumin, total protein, glutamic oxalacetic transaminase, glutamic pyruvic transaminase, urea, creatinine);fasting blood glucose; | — |
Countries
China
Contacts
Public ContactJin Sun
Medical College of Qingdao University
Outcome results
None listed